Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness

Repository

Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness

Show full record

Title: Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness
Author: Tiller, Kevin Wade
Abstract: Not available
Department: Pharmacy
Subject: Osteoporosis in women--Treatment--Cost effectiveness Osteoporosis in women--Prevention--Cost effectiveness Osteoporosis in women--Treatment Osteoporosis in women--Risk factors Osteoporosis in women--Epidemiology Osteoporosis in women--Hormone therapy--Cost effectiveness Osteoporosis in women--Hormone therapy
URI: http://hdl.handle.net/2152/1271
Date: 2004

Files in this work

Download File: tillerd10698.pdf
Size: 1.288Mb
Format: application/pdf

This work appears in the following Collection(s)

Show full record


Advanced Search

Browse

My Account

Statistics

Information